annual cash & cash equivalents:
$582.24M+$148.75M(+34.31%)Summary
- As of today (May 29, 2025), ASND annual cash & cash equivalents is $582.24 million, with the most recent change of +$148.75 million (+34.31%) on December 31, 2024.
- During the last 3 years, ASND annual cash & cash equivalents has risen by +$76.97 million (+15.23%).
- ASND annual cash & cash equivalents is now -19.01% below its all-time high of $718.93 million, reached on December 31, 2020.
Performance
ASND Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$560.56M-$21.68M(-3.72%)Summary
- As of today (May 29, 2025), ASND quarterly cash & cash equivalents is $560.56 million, with the most recent change of -$21.68 million (-3.72%) on March 31, 2025.
- Over the past year, ASND quarterly cash & cash equivalents has increased by +$214.74 million (+62.09%).
- ASND quarterly cash & cash equivalents is now -37.46% below its all-time high of $896.33 million, reached on September 30, 2020.
Performance
ASND quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ASND Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.3% | +62.1% |
| 3 y3 years | +15.2% | -33.5% |
| 5 y5 years | -13.1% | -4.9% |
ASND Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.3% | -33.5% | +102.2% |
| 5 y | 5-year | -19.0% | +34.3% | -37.5% | +107.2% |
| alltime | all time | -19.0% | +2929.0% | -37.5% | +5485.7% |
ASND Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $560.56M(-3.7%) |
| Dec 2024 | $582.24M(+34.3%) | $582.24M(-16.7%) |
| Sep 2024 | - | $698.64M(+151.9%) |
| Jun 2024 | - | $277.30M(-19.8%) |
| Mar 2024 | - | $345.83M(-20.2%) |
| Dec 2023 | $433.50M(-9.1%) | $433.50M(-7.2%) |
| Sep 2023 | - | $467.08M(+9.0%) |
| Jun 2023 | - | $428.42M(-21.6%) |
| Mar 2023 | - | $546.62M(+14.6%) |
| Dec 2022 | $476.97M(-5.6%) | $476.97M(-20.2%) |
| Sep 2022 | - | $597.92M(-14.9%) |
| Jun 2022 | - | $702.37M(-16.7%) |
| Mar 2022 | - | $843.39M(+66.9%) |
| Dec 2021 | $505.27M(-29.7%) | $505.27M(-37.1%) |
| Sep 2021 | - | $803.74M(+75.6%) |
| Jun 2021 | - | $457.61M(-21.1%) |
| Mar 2021 | - | $580.34M(-19.3%) |
| Dec 2020 | $718.93M(+7.3%) | $718.93M(-19.8%) |
| Sep 2020 | - | $896.33M(+231.2%) |
| Jun 2020 | - | $270.60M(-54.1%) |
| Mar 2020 | - | $589.39M(-12.0%) |
| Dec 2019 | $669.98M | $669.98M(-7.0%) |
| Sep 2019 | - | $720.64M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $784.93M(+0.3%) |
| Mar 2019 | - | $782.35M(+146.1%) |
| Dec 2018 | $317.85M(+35.6%) | $317.85M(-11.9%) |
| Sep 2018 | - | $360.61M(-11.5%) |
| Jun 2018 | - | $407.68M(-5.1%) |
| Mar 2018 | - | $429.55M(+83.3%) |
| Dec 2017 | $234.36M(+22.9%) | $234.36M(-3.6%) |
| Sep 2017 | - | $243.03M(+66.9%) |
| Jun 2017 | - | $145.65M(-13.5%) |
| Mar 2017 | - | $168.47M(-11.6%) |
| Dec 2016 | $190.64M(+45.7%) | $190.64M(+128.0%) |
| Sep 2016 | - | $83.61M(-17.2%) |
| Jun 2016 | - | $100.95M(-12.6%) |
| Mar 2016 | - | $115.45M(-11.7%) |
| Dec 2015 | $130.81M(+114.4%) | $130.81M(-9.3%) |
| Sep 2015 | - | $144.30M(-6.7%) |
| Jun 2015 | - | $154.62M(-7.0%) |
| Mar 2015 | - | $166.17M(+172.4%) |
| Dec 2014 | $61.00M(+127.4%) | $61.00M(+507.9%) |
| Sep 2014 | - | $10.04M(-62.6%) |
| Dec 2013 | $26.83M(+39.6%) | $26.83M |
| Dec 2012 | $19.22M(-5.4%) | - |
| Dec 2011 | $20.31M | - |
FAQ
- What is Ascendis Pharma A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
- What is Ascendis Pharma A/S quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly cash & cash equivalents year-on-year change?
What is Ascendis Pharma A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of ASND is $582.24M
What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash & cash equivalents is $718.93M
What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
Over the past year, ASND annual cash & cash equivalents has changed by +$148.75M (+34.31%)
What is Ascendis Pharma A/S quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ASND is $560.56M
What is the all time high quarterly cash & cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash & cash equivalents is $896.33M
What is Ascendis Pharma A/S quarterly cash & cash equivalents year-on-year change?
Over the past year, ASND quarterly cash & cash equivalents has changed by +$214.74M (+62.09%)